Valuation : Rapid Micro Biosystems, Inc.

Market Cap 65.71M 56.54M 53.2M 48.6M 90.91M 6.2B 91.16M 629M 244M 3.18B 247M 241M 10.25B P/E 2026 *
-1.4x
P/E 2027 * -1.8x
Enterprise Value 65.71M 56.54M 53.2M 48.6M 90.91M 6.2B 91.16M 629M 244M 3.18B 247M 241M 10.25B EV / Sales 2026 *
1.67x
EV / Sales 2027 * 1.41x
Free-Float
81.07%
Yield 2026 *
-
Yield 2027 * -
1 day-5.07%
1 week-16.56%
Current month-13.82%
1 month-37.91%
3 months-34.17%
6 months-68.59%
Current year-54.83%
1 week 1.29
Extreme 1.29
1.61
1 month 1.29
Extreme 1.29
2
Current year 1.29
Extreme 1.29
4.94
1 year 1.29
Extreme 1.29
4.94
3 years 0.58
Extreme 0.58
4.94
5 years 0.58
Extreme 0.58
22.71
10 years 0.58
Extreme 0.58
27.04
Manager TitleAgeSince
Chief Executive Officer 57 2014-09-30
Director of Finance/CFO 56 2018-09-30
Chief Tech/Sci/R&D Officer - 2025-04-30
Director TitleAgeSince
Director/Board Member 56 2018-09-30
Director/Board Member 57 2014-09-30
Director/Board Member 77 2016-03-14
Date Insider Type Main position Quantity % Market Cap. Importance
7/24/26 Exercice

Director

7,016 0.0155%
7/22/26 Exercice

Chief Executive Officer

2,804 0.0062%
5/29/26 Free

Director

38,361 0.0921%
Change 5-day change 1-year change 3-year change Capi.($)
-5.07%-16.56%-51.84%+39.24% 65.71M
-0.75%-1.35%+24.60%+13.24% 227B
-1.60%-3.89%+3.72%-20.39% 146B
-0.85%-1.58%-21.45%+19.18% 130B
+1.81%+2.05%-55.42%-10.32% 69.27B
+0.13%-0.34%+11.07%+18.34% 51.82B
+0.49%-1.32%-17.44%-13.87% 50.45B
+0.59%-1.94%+17.17%+27.06% 42.53B
-1.01%-1.28%+33.64%+48.14% 40.22B
-1.55%+1.22%+120.58%+36.88% 32.95B
Average -0.78%-3.06%+6.46%+15.75% 78.98B
Weighted average by Cap. -0.54%-1.55%+6.65%+8.04%

Financials

2026 *2027 *
Net sales 39.32M 33.84M 31.84M 29.08M 54.41M 3.71B 54.56M 376M 146M 1.9B 148M 144M 6.14B 46.5M 40.01M 37.65M 34.39M 64.33M 4.39B 64.51M 445M 173M 2.25B 175M 171M 7.26B
Net income -44.53M -38.32M -36.05M -32.94M -61.61M -4.2B -61.78M -426M -165M -2.16B -167M -164M -6.95B -35.83M -30.83M -29.01M -26.5M -49.58M -3.38B -49.71M -343M -133M -1.74B -135M -132M -5.59B
Net Debt - -
Logo Rapid Micro Biosystems, Inc.
Rapid Micro Biosystems, Inc. is a life sciences technology company providing mission-critical automation solutions to facilitate the manufacturing and release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. Its flagship Growth Direct system automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in pharmaceutical manufacturing operations. It offers four specific applications for testing of microbial contamination: Environmental Monitoring, which tests the manufacturing environment, including circulating air, exposed surfaces, and personnel; Water, which tests any purified water used at any stage of the drug production process, including water for injection; In-Process Bioburden, which tests raw materials, drug substance and in-process product, and Sterility Release offering final testing of finished product to ensure sterility before the product is released for commercial sale.
Employees
171
Date Price Change Volume
26-09-04 US$1.310 -5.07% 378,832
26-09-03 US$1.380 -0.72% 107,263
26-09-02 US$1.390 -7.33% 204,976
26-09-01 US$1.500 -1.32% 167,545
26-08-31 US$1.520 -3.18% 198,812
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
1.310USD
Average target price
6.667USD
Spread / Average Target
+408.91%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. RPID Stock